We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $3.98B
1-Year Est. Return 20.52%
This Fund
S&P 500
This Quarter Est. Return
-17.12%
1 Year Est. Return
+20.52%
3 Year Est. Return
+68.18%
5 Year Est. Return
+87.14%
10 Year Est. Return
+400.35%
AUM
$10.3B
AUM Growth
-$5.42B
Cap. Flow
-$3B
Cap. Flow %
-29.02%
Top 10 Hldgs %
54.96%
Holding
62
New
4
Increased
17
Reduced
26
Closed
12

Top Buys

Rank Stock Value
1
CI icon
Cigna
CI
+$363M
2
DXC icon
DXC Technology
DXC
+$306M
3
SHPG
Shire pic
SHPG
+$285M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$144M
5
CVS icon
CVS Health
CVS
+$140M

Top Sells

Rank Stock Value
1
ESRX
Express Scripts Holding Company
ESRX
+$817M
2
AET
Aetna Inc
AET
+$732M
3
NWL icon
Newell Brands
NWL
+$394M
4
TMO icon
Thermo Fisher Scientific
TMO
+$242M
5
AGN
Allergan plc
AGN
+$240M

Sector Composition

Rank Sector Weight
1 Healthcare 53.29%
2 Materials 13%
3 Technology 8.91%
4 Industrials 8.58%
5 Communication Services 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SHPG
1
DELISTED
Shire pic
SHPG
$794M 7.69%
4,563,127
+1,631,146
+56% +$285M
FMC icon
2
FMC
FMC
$1.32B
$659M 6.38%
10,276,521
+445,070
+5% +$31.2M
IQV icon
3
IQVIA
IQV
$38.3B
$623M 6.03%
5,362,932
+65,955
+1% +$7.99M
HCA icon
4
HCA Healthcare
HCA
$88.5B
$610M 5.9%
4,898,569
+563,467
+13% +$75.6M
CVS icon
5
CVS Health
CVS
$123B
$556M 5.39%
8,489,991
+1,875,037
+28% +$140M
CI icon
6
Cigna
CI
$72.7B
$516M 5%
2,718,586
+1,738,013
+177% +$363M
MCK icon
7
McKesson
MCK
$102B
$499M 4.84%
4,520,886
-346,705
-7% -$43.2M
DXC icon
8
DXC Technology
DXC
$1.77B
$490M 4.74%
9,213,636
+4,428,652
+93% +$306M
GOOGL icon
9
Alphabet (Google) Class A
GOOGL
$4.38T
$466M 4.51%
8,921,020
+2,656,200
+42% +$144M
DD icon
10
DuPont de Nemours
DD
$19.5B
$461M 4.46%
3,402,090
-557,868
-14% -$80.1M
FDC
11
DELISTED
First Data Corporation
FDC
$436M 4.22%
25,777,193
+3,771,164
+17% +$73.5M
HOLX
12
DELISTED
Hologic
HOLX
$407M 3.95%
9,914,043
+1,578,935
+19% +$64.8M
THC icon
13
Tenet Healthcare
THC
$20.7B
$307M 2.97%
17,895,314
– –
TMO icon
14
Thermo Fisher Scientific
TMO
$214B
$263M 2.55%
1,176,841
-1,033,101
-47% -$242M
ELV icon
15
Elevance Health
ELV
$84.9B
$229M 2.22%
872,433
-414,516
-32% -$114M
UHS icon
16
Universal Health Services
UHS
$10.3B
$229M 2.22%
1,962,547
-829,021
-30% -$104M
EBAY icon
17
eBay
EBAY
$48.9B
$202M 1.96%
7,192,991
-4,384,445
-38% -$129M
WMB icon
18
Williams Companies
WMB
$87.8B
$194M 1.88%
8,813,133
+254,818
+3% +$6.37M
PARA
19
DELISTED
Paramount Global Class B
PARA
$179M 1.73%
4,085,751
-179,161
-4% -$9.52M
NVT icon
20
nVent Electric
NVT
$26.4B
$150M 1.45%
6,657,097
+500,000
+8% +$12.1M
MTOR
21
DELISTED
MERITOR, Inc.
MTOR
$140M 1.36%
8,299,201
-94,807
-1% -$1.62M
MSFT icon
22
Microsoft
MSFT
$3.71T
$127M 1.23%
1,252,751
-148,390
-11% -$15.9M
BHC icon
23
Bausch Health
BHC
$2.21B
$122M 1.18%
6,590,308
+3,060,703
+87% +$72.8M
FLEX icon
24
Flex
FLEX
$45.3B
$119M 1.15%
20,790,884
-2,571,861
-11% -$18M
LBTYA icon
25
Liberty Global Class A
LBTYA
$3.68B
$109M 1.06%
5,112,109
-580,756
-10% -$14.2M
1
2 3

Similar funds

MAM
Martingale Asset Management Boston, Massachusetts $3.99B AUM 22.65% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return

Glenview Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, Glenview Capital Management held 62 positions worth $10.3B, down 34% from $15.7B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Glenview Capital Management withdrew a net $3B in Q4 2018, closing 12 positions and reducing 26 holdings. Its most notable exit was Express Scripts Holding Company, an estimated $817M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 53% of assets, up from 46% a quarter earlier, followed by Materials and Technology.

Against the trend, Glenview Capital Management opened a new position in Baxter International worth $57.7M.

  • Glenview Capital Management's largest Q4 2018 buy was Baxter International: 877,001 shares worth $57.7M.
  • Glenview Capital Management added most to Cigna in Q4 2018, an estimated $363M increase.
  • Glenview Capital Management's biggest Q4 2018 reduction was Thermo Fisher Scientific, cutting an estimated $242M.
  • Glenview Capital Management fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $817M.
  • Glenview Capital Management's ten largest holdings make up 55% of its $10.3B portfolio in Q4 2018.
  • Glenview Capital Management opened 4 new positions and closed 12 in Q4 2018.
  • Glenview Capital Management's portfolio value fell 34% quarter-over-quarter to $10.3B.

Based on Glenview Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.